Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIA

Method of Using a Beta2-Adrenergic Receptor Agonist That Selectively Activates GS Proteins in the Treatment of Cardiovascular Disease

  • Read more about Method of Using a Beta2-Adrenergic Receptor Agonist That Selectively Activates GS Proteins in the Treatment of Cardiovascular Disease
US Application 60/102,475
Filed on 1998-09-30

INSULIN PRODUCING CELLS DIFFEREINTIATED FROM NON-INSULIN PRODUCING CELLS BY GLP-1 AND EXENDIN-4 AND USES THEREOF

  • Read more about INSULIN PRODUCING CELLS DIFFEREINTIATED FROM NON-INSULIN PRODUCING CELLS BY GLP-1 AND EXENDIN-4 AND USES THEREOF
US Application 60/095,917
Filed on 1998-08-10

HIGHLY SELECTIVE BUTYRYLCHOLINESTERASE INHIBITORS FOR THE TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE AND DEMENTIAS

  • Read more about HIGHLY SELECTIVE BUTYRYLCHOLINESTERASE INHIBITORS FOR THE TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE AND DEMENTIAS
US Application 60/052,087
Filed on 1997-07-09

A NOVEL ADIPOSE SEVEN TRANSMEMBRANE DOMAIN PROTEIN

  • Read more about A NOVEL ADIPOSE SEVEN TRANSMEMBRANE DOMAIN PROTEIN
US Application 60/050,170
Filed on 1997-06-19

GINGERENONE A PRODRUGS AS SENOTHERAPEUTICS AND METHODS OF USE

  • Read more about GINGERENONE A PRODRUGS AS SENOTHERAPEUTICS AND METHODS OF USE
US Application 18/780,981
Filed on 2024-07-23

GINGERENONE A PRODRUGS AS SENOTHERAPEUTICS AND METHODS OF USE

  • Read more about GINGERENONE A PRODRUGS AS SENOTHERAPEUTICS AND METHODS OF USE
US Application 18/832,248
Filed on 2024-07-23

FATTY ACID DERIVATIVES AND THEIR USE

  • Read more about FATTY ACID DERIVATIVES AND THEIR USE
United Kingdom
18746415.1
Filed on 2018-07-06

COMPOUNDS FOR TREATING OR PREVENTING ALZHEIMER'S DISEASE

  • Read more about COMPOUNDS FOR TREATING OR PREVENTING ALZHEIMER'S DISEASE
US Application 18/627,191
Filed on 2024-04-04

METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM AND METHODS OF TREATING A CENTRAL NERVOUS SYSTEM DISEASE

  • Read more about METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM AND METHODS OF TREATING A CENTRAL NERVOUS SYSTEM DISEASE
Singapore
10202303473R
Filed on 2023-12-11

ISLET AMYLOID POLYPEPTIDE ISOFORMS AND PEPTIDES AND METHODS OF USE

  • Read more about ISLET AMYLOID POLYPEPTIDE ISOFORMS AND PEPTIDES AND METHODS OF USE
Patent Cooperation Treaty
PCT/US2023/077173
Filed on 2023-10-18

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIA
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health